SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Labs Confirm RHB-204 MAP-Killing Effect

Two labs confirmed a MAP-killing effect for RedHill’s Crohn’s disease candidate RHB-204.

Related stories